Exec Chat: GE's Connecting The Dots To Stay On Top

Precision health is gathering momentum and this trend brings opportunities for companies to enable a more tailored approach to health care. GE Healthcare's chief strategy and commercial officer Tom McGuinness tells Medtech Insight how the health-tech giant has been working to "connect the dots" to make precision health a reality, and in doing so is allowing the company to sustain growth and stay on top in an evolving landscape.

Businessman
GE Healthcare's Tom McGuinness discusses business strategies

Getting to the top is hard, but staying there is even harder. One can only imagine the weight of responsibility on the shoulders of that person charged with keeping a market leader ahead of the game while beating down potential competitors hungry to take more share. Tom McGuinness is that person who, as current chief strategy and commercial officer at GE Healthcare, is responsible for ensuring the company stays as leader across the broad range of markets it operates in, not least diagnostic imaging, where GE Healthcare has been – and still is – the No. 1 player. (See Medtech Insight's MTI100 league tables to see where GE Healthcare sits in 2017's rankings.)

However, McGuinness does not seem too fazed by this task. He believes that GE Healthcare's established strengths have given him...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business

Innovative Wants Injunction Against J&J Subsidiary After $442M Antitrust Verdict

 
• By 

Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.

Philips Deals Itself A Strong Hand In POCUS Stakes

 
• By 

Point of care ultrasound technology that can be used by non-sonographers will plug gaps in workforce coverage and bring new critical care capabilities to the frontline of care, said Royal Philips.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.